23 July 2019 – AGM statement

A trading update released to coincide with the company’s AGM has revealed that performance in the year to date has been in line with expectations.  Strong growth in Healthcare revenues means that group revenues grew by 18.7% on a continuing basis.  There was organic growth from both the Healthcare and Industrial segments of the business and acquired businesses have been a key driver of overall growth.  We continue to rate the shares as a BUY following our recent recommendation.